Juntendo Medical Journal
Online ISSN : 2759-7504
Print ISSN : 2187-9737
ISSN-L : 2187-9737
Current issue
Displaying 1-9 of 9 articles from this issue
Contents
Reviews: 356th Triannual Meeting of the Juntendo Medical Society “Medical Research Update” [2]
  • KIICHI SUGIMOTO
    2025 Volume 71 Issue 3 Pages 148-155
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: May 09, 2025
    JOURNAL OPEN ACCESS

    I (the author) received the 44th Juntendo Medical School Alumni Association Academic Encouragement Award in May 2022. After graduating from Juntendo University School of Medicine in 2002, I trained in the Department of Coloproctological Surgery at Juntendo University, led by Professor Toshiki Kamano and Professor Kazuhiro Sakamoto. I then studied DNA methylation in cancer at Johns Hopkins University in Maryland in the United States of America from December 2013 to July 2016. I worked in the laboratory of Professor Malcolm V Brock, a thoracic surgeon, in the Department of Thoracic Surgery. The subject of this translational research was ‘Epigenetics’, and specifically DNA methylation in lung and esophageal cancer. Epigenetics is the study of potentially heritable changes in gene expression that do not involve changes to the underlying DNA sequence, while genetics involves changes to the underlying DNA sequence. In epigenetic alterations, methyl marks added to certain bases repress gene activity by tightly packing the chromatin. Recently, there have been many attempts to apply epigenetics to clinical diagnosis, treatment and prevention.

    Colorectal cancer is a global cause of death and an increasingly common disease worldwide. To predict and improve long-term outcomes in CRC, a wide variety of perioperative biomarkers, including imaging markers, blood markers, and pathological and molecular markers, have been reported as prognostic factors. This review includes a description of three of our previous studies on DNA methylation and summarizes the potential clinical usefulness of the findings in precision medicine for colorectal cancer.

    Download PDF (1960K)
Reviews: Research of the 8th Alumni Scientific Award for Medical Student, Juntendo University School of Medicine [1]
Reviews
  • HITOSHI IIDA, HIROTAKA WATADA
    2025 Volume 71 Issue 3 Pages 158-165
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: May 09, 2025
    JOURNAL OPEN ACCESS

    The prevalence of diabetes continues to increase globally, posing a pressing issue for healthcare. Diabetes is primarily characterized by hyperglycemia, resulting from an absolute or relative deficiency in insulin activity, and is associated with systemic micro- and macro-vascular complications. Although diabetes encompasses multiple pathophysiological conditions based on its underlying mechanisms, pancreatic β-cell dysfunction is a common feature.

    Pancreatic β-cells play a critical role in maintaining normal blood glucose levels by producing and secreting insulin in response to blood glucose concentrations. However, when β-cell dysfunction occurs, the cells fail to supply sufficient insulin to meet peripheral insulin demands, resulting in elevated blood glucose levels. Although multiple mechanisms contribute to β-cell impairment, these mechanisms often share overlapping pathways and can interact to exacerbate their detrimental effects.

    Understanding the causes of β-cell dysfunction is essential for the prevention and treatment of diabetes. This review highlights the primary functions of pancreatic β-cells, including insulin biosynthesis and secretion, and provides an overview of the molecular mechanisms underlying β-cell dysfunction.

    Download PDF (514K)
Perspectives: 52nd Health Topics for Tokyoites “The Frontier of Healthcare: Artificial Intelligence and Data Science” [3]
  • TOSHIAKI AKASHI, KANAKO K. KUMAMARU, AKIHIKO WADA, MASAHIRO HASHIMOTO, ...
    2025 Volume 71 Issue 3 Pages 166-172
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: June 04, 2025
    JOURNAL OPEN ACCESS

    The digitization of radiology practices has advanced for nearly two decades, exemplified by the global standard Digital Imaging and Communications in Medicine (DICOM). Rapid technological progress in imaging modalities has led to a significant increase in the volume of data handled. However, it has become difficult for the limited number of radiologists in Japan to maintain the quality of diagnosis while efficiently processing the data. In response, the Japan Radiological Society (JRS) advocated the “Japan Safe Radiology” Initiative, which aims to improve the safety, efficiency, and quality of radiological medicine by actively utilizing information and communication technology (ICT) in all aspects of radiological practice.

    Recent advances in innovative artificial intelligence (AI) technology have shown a high affinity for image processing, prompting recognition of the importance of using big data systems to integrate radiological medicine. Consequently, in 2017, the Japan Agency for Medical Research and Development (AMED) supported the JRS project, Development Research for the Realization of a National Image Diagnosis Database, through which the Japan Medical Image Database (J-MID) was established.

    The J-MID is designed to centralize medical resources and systematically collect CT/MR images and diagnostic reports from 10 major university hospitals in Japan through an academic information network (SINET). Data were anonymized and stored on a central server in the cloud, enabling researchers to utilize J-MID conveniently. In April 2024, J-MID had collected more than 534 million images (1.65 million cases), making it an unparalleled repository of real-world radiological data in Japan.

    Download PDF (5159K)
Original Articles
  • HIROKI TAKAMI, TAKASHI MITSUHASHI, DAISUKE USUDA, TOMOHISA NOMURA, MAN ...
    2025 Volume 71 Issue 3 Pages 173-179
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: April 18, 2025
    JOURNAL OPEN ACCESS

    Objectives Healthcare workers must take stringent infection control measures against coronavirus disease. Previous reports have indicated that N95 respirators cause fatigue, discomfort, and physical symptoms, such as headaches. We aimed to comparatively analyze the effect of the use of surgical and N95 respirators for long hours on the performance of healthcare workers. This is the first study to validate the effect of wearing N95 respirators on work efficiency.

    Materials and Methods This study was conducted from April 2021 to October 2021 during the COVID-19 pandemic in Japan. Healthy healthcare workers at an emergency department were subjected to a performance task program comprising four tasks conducted before and after wearing a surgical mask/N95 respirator for at least 4 h, and the results were compared.

    Results The study included 17 (male, 8 [47.1%]) healthcare workers. The age ranged from 22 to 32 (mean, 26.6) years. For each task, the rate of change in the percentage of correct responses, rate of decline in reaction time, and rate of decline in reaction time for correct responses were calculated before and after wearing the two types of masks. There was no statistically significant difference in the rate of decline in reaction time between the masks for all tasks. However, there was a trend toward a high rate of decline in the alphanumeric detection task.

    Conclusions Using an N95 respirator for 4 h continuously did not adversely affect work efficiency. Although prolonged work under conditions of discomfort should be avoided, it is unlikely that N95 respirators will adversely affect the performance of healthcare workers.

    Download PDF (329K)
  • MARIKO AKIMOTO, DAIZOH SATOH, IZUMI KAWAGOE, YURI OOIZUMI-GOTO, CHIEKO ...
    2025 Volume 71 Issue 3 Pages 180-186
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: June 04, 2025
    JOURNAL OPEN ACCESS

    Objectives Minimally invasive thoracoscopic esophagectomy may result in superior post-operative outcomes compared to open esophagectomy. We compared arterial blood gas data during one-lung ventilation (OLV) between thoracoscopic esophagectomy and open esophagectomy.

    Design 37 patients undergoing thoracoscopic esophagectomy (Group E) and 38 patients undergoing open esophagectomy (Group O) were investigated.

    Methods Arterial blood gas was analysed during two-lung ventilation (TLV) immediately before surgery (T1), during OLV for thoracic procedures (T2), during TLV for abdominal procedures (T3) and during spontaneous breathing immediately before extubation (T4).

    Results Respiratory function data did not differ between the groups, even though the patients were older (p < 0.05) and the operative time was longer (p < 0.01) in Group E than in Group O. At T2, PaO2/FIO2 was lower (p < 0.01) and PaCO2 was higher (p < 0.01) in Group E than in Group O, although these variables did not differ between groups at T1 or T4. Post operative data showed shorter ICU (p < 0.01) and hospital stay (p < 0.05) in Group E than in Group O but showed no significant difference in the presence of complications.

    Conclusions PaO2/FIO2 decreased and PaCO2 increased during OLV for thoracoscopic esophagectomy compared to open esophagectomy. Although thoracoscopic esophagectomy was inferior to open esophagectomy regarding gas exchange during OLV, patients in Group E required less ICU stay and less hospital stay than patients in Group O. The benefits of minimally invasive thoracoscopic esophagectomy may outweigh disadvantages regarding gas exchange during the surgery.

    Download PDF (279K)
  • MEGUMI KAWAGUCHI, MASAYA KAWAI, SHINYA MUNAKATA, HARUNA ISHIHARA, YUKI ...
    2025 Volume 71 Issue 3 Pages 187-194
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: June 06, 2025
    JOURNAL OPEN ACCESS

    Introduction In the tumor microenvironment, macrophages function as M1 macrophages, which cause cytotoxicity to tumor cells in the early stages, and M2 macrophages, which contribute to the proliferation of cancer cells in the late stages. This study aimed to examine the mechanism of action of macrophages in ascites using a peritoneal dissemination mouse model of colorectal cancer.

    Materials and Methods Mouse models of peritoneal dissemination were created by injecting murine colorectal cancer cells into the abdominal cavity of non-obese diabetic/severely combined immunodeficient mice. Surface markers for M1 (CD38, CD68) and M2 (CD83, CD206) were used for macrophage differentiation via flow cytometry. Quantitative PCR and microarray gene expression analyses were performed on macrophages isolated from ascites. Additionally, a macrophage inhibitor (clodronate) and IL-10 inhibitor (AS101) were injected intra-abdominally, and the weight of peritoneally disseminated nodules was compared.

    Results M1 macrophage counts showed no change over time, while M2 counts and the expression of arginase 1 and IL-10 increased. Clodronate administration significantly reduced the weight of peritoneally disseminated nodules. and AS101 administration reduced tumor size.

    Conclusion Our findings indicate that cytokine and gene expression analyses of TAMs should be further explored to improve targeted anticancer therapy

    Download PDF (8952K)
  • MAYU KAWAMURA, YAYOI KAMATA, ERIKO KOMIYA, CATHARINA SAGITA MONIAGA, N ...
    2025 Volume 71 Issue 3 Pages 195-201
    Published: 2025
    Released on J-STAGE: June 30, 2025
    Advance online publication: April 18, 2025
    JOURNAL OPEN ACCESS

    Objectives Although the opioid system is critical for regulating itch within the central nervous system, its role in managing severe, treatment-resistant itch related to skin diseases is unclear. Serum lipocalin-2 (LCN-2) levels are associated with the visual analogue scale score of itch in patients with psoriasis vulgaris (PSO), but not other itchy skin diseases. Therefore, we herein investigated the relationship between opioids and LCN-2 with itch in pruritic skin diseases.

    Methods We assessed plasma levels of β-endorphin and dynorphin A and serum levels of LCN-2 in patients with pruritic skin diseases using enzyme-linked immunosorbent assays.

    Results Plasma dynorphin A levels were significantly reduced in patients with urticaria, and asteatotic dermatitis (AsD), while β-endorphin levels were significantly elevated in those with AsD. The plasma β-endorphin-to-dynorphin A ratio was markedly higher in AsD patients than in healthy controls. Among the patients examined, only those with PSO had significantly elevated serum LCN-2 levels, which correlated with VAS and severity index scores and also with the area of affected skin.

    Conclusions The present results suggest that the ratio of plasma opioids is involved in itch control in AsD patients, and serum LCN-2 levels may be a biomarker for itch and its severity in those with PSO.

    Download PDF (768K)
feedback
Top